Global Intrauterine Contraceptive Report Thumbnail

Global Intrauterine Contraceptive Market by Type (Hormonal IUCD, Copper IUCD), By Application (Hospitals, Gynecological Clinics, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: MDC-711
  • Author: Up Market Research
  • Rating: 4.6
  • Total Reviews: 93
  • No. Of Pages: 219
  • Format:
  • Pub. Date: 2021-03-01
  • Share:

The Global Intrauterine Contraceptive Market size is expected to reach USD $1.2 billion by 2028, growing at a CAGR of 5.9% during the forecast period from 2021 to 2028. The key factors driving the growth of this market are rising awareness about unplanned pregnancies and the increasing rate of adoption due to advancements in technology. Rising prevalence rates for infertility are also contributing significantly towards market growth.


Intrauterine Contraceptive (IUDs) are small, contraceptive devices that a doctor inserts into the uterus. They may be referred to as intrauterine contraception or an IUC. Intrauterine Contraceptives (IUCD) is a highly effective form of birth control for women with up to 95% effectiveness in preventing pregnancy and can last between five and twelve years depending on the type. The first IUCD was introduced in the 1970s and has seen major development since then including various shapes, sizes, materials, hormones used, etc. In recent studies, it’s been found that copper-releasing IUDs have very high levels of success when compared to other types which make them popular among doctors around the world.


On the basis of Type, the market is segmented into Hormonal IUCD and Copper IUCD. Copper IUCDs are being used more than hormonal because it has lower side effects such as nausea or acne which are common with women who take estrogen-containing contraceptives.


Hormonal IUCD:

Hormonal IUCD is a type of intrauterine contraceptive, which prevents pregnancy by releasing hormones into the uterus. Hormonal IUDs are available in different types such as Mirena and Skyla or Liletta and Kyleena. The Hormonal IUDs segment is further bifurcated into Levonorgestrel-releasing Intrauterine System, Depot Medroxyprogesterone Acetate (DMPA)-releasing Intrauterine System and Other.


Copper IUCD:

Copper IUCD is a long-acting, nonhormonal intrauterine device that can be used for birth control. A copper IUD works by releasing small amounts of copper into the uterus which then creates an inflammatory reaction and at the same time releases natural prostaglandin to thicken cervical mucus preventing sperm from fertilizing eggs in parts or fallopian tubes.

The Copper One Intra-Uterine Device (IUCD) has been one of the most popular forms of contraception worldwide since its first introduction in 1988. Its efficacy rates are very high as it provides almost 100% protection against pregnancy while also providing some other benefits such as reduced menstrual cramps, lighter periods, and better general health due to less exposure to hormones.


On the basis of Application, the market is segmented into Hospitals, Gynecological Clinics, Other. There are various types of Intrauterine contraceptives available in hospitals, and they are used for different purposes. The Hospital segment is projected as the largest revenue generator by 2021. Hospitals offer services such as family planning clinics, emergency care centers, or delivery rooms which helps to access IUCDs on time thus having more chances of preventing unwanted pregnancies without any side effects like oral pills.


On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is expected to dominate the global intrauterine contraceptive market. The rise in awareness about contraceptives and their benefits among women is likely to drive this region's growth in the future.

Europe, Asia Pacific, and Middle East & Africa are also estimated to be growing regions for this market due to an increase in the population of females aged between 15-49 years globally where these segments can find a huge potential for increasing demand for IUCDs.


Growth Factors For The Global Intrauterine Contraceptive Market:

Increasing contraceptive prevalence and population are the prime factors of growth in this market. One of the most important reasons for the use of Intrauterine devices is their efficacy, which can be given from preventing pregnancy with up to 99% effectiveness. In addition, it has fewer side effects as compared to other forms such as oral contraceptives that have a higher risk of getting pregnant again soon after stopping or starting another form.


Up Market Research published a new report titled “Intrauterine Contraceptive Market research report which is segmented by Types (Hormonal IUCD, Copper IUCD), By Applications (Hospitals, Gynecological Clinics, Other), By Players/Companies Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network, Bayer Healthcare, Actavis, Medisafe Distribution, Pace Pharmaceuticals”. 


Report Scope

Report Attributes Report Details
Report Title Intrauterine Contraceptive Market Research Report
By Type Hormonal IUCD, Copper IUCD
By Application Hospitals, Gynecological Clinics, Other
By Companies Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network, Bayer Healthcare, Actavis, Medisafe Distribution, Pace Pharmaceuticals
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2020
Historical Year 2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year 2028
Number of Pages 219
Number of Tables & Figures 154
Customization Available Yes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Intrauterine Contraceptive Industry Outlook

Global Intrauterine Contraceptive Market Report Segments:

The market is segmented by Type Hormonal IUCD, Copper IUCD and By Application Hospitals, Gynecological Clinics, Other.


Some of the companies that are profiled in this report are:

  1. Teva Pharmaceutical Industries
  2. Medicines360
  3. Trimedic Supply Network
  4. Bayer Healthcare
  5. Actavis
  6. Medisafe Distribution
  7. Pace Pharmaceuticals

Intrauterine Contraceptive Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Intrauterine Contraceptive Market

Overview of the regional outlook of the Intrauterine Contraceptive Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Intrauterine Contraceptive Market Overview

Highlights of The Intrauterine Contraceptive Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Intrauterine Contraceptive Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Hormonal IUCD

                2. Copper IUCD

       7. By Application:

                1. Hospitals

                2. Gynecological Clinics

                3. Other

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Intrauterine Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Intrauterine Contraceptive Market Statistics

Reasons to Purchase the Intrauterine Contraceptive Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrauterine Contraceptive Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Intrauterine Contraceptive Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Intrauterine Contraceptive Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Intrauterine Contraceptive Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Intrauterine Contraceptive Market Size & Forecast, 2018-2028 
      4.5.1 Intrauterine Contraceptive Market Size and Y-o-Y Growth 
      4.5.2 Intrauterine Contraceptive Market Absolute $ Opportunity 

Chapter 5 Global Intrauterine Contraceptive Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Intrauterine Contraceptive Market Size Forecast by Type
      5.2.1 Hormonal IUCD
      5.2.2 Copper IUCD
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Intrauterine Contraceptive Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Intrauterine Contraceptive Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Gynecological Clinics
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Intrauterine Contraceptive Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Intrauterine Contraceptive Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Intrauterine Contraceptive Analysis and Forecast
   9.1 Introduction
   9.2 North America Intrauterine Contraceptive Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Intrauterine Contraceptive Market Size Forecast by Type
      9.6.1 Hormonal IUCD
      9.6.2 Copper IUCD
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Intrauterine Contraceptive Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Gynecological Clinics
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Intrauterine Contraceptive Analysis and Forecast
   10.1 Introduction
   10.2 Europe Intrauterine Contraceptive Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Intrauterine Contraceptive Market Size Forecast by Type
      10.6.1 Hormonal IUCD
      10.6.2 Copper IUCD
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Intrauterine Contraceptive Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Gynecological Clinics
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Intrauterine Contraceptive Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Intrauterine Contraceptive Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Intrauterine Contraceptive Market Size Forecast by Type
      11.6.1 Hormonal IUCD
      11.6.2 Copper IUCD
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Intrauterine Contraceptive Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Gynecological Clinics
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Intrauterine Contraceptive Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Intrauterine Contraceptive Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Intrauterine Contraceptive Market Size Forecast by Type
      12.6.1 Hormonal IUCD
      12.6.2 Copper IUCD
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Intrauterine Contraceptive Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Gynecological Clinics
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Intrauterine Contraceptive Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Intrauterine Contraceptive Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Intrauterine Contraceptive Market Size Forecast by Type
      13.6.1 Hormonal IUCD
      13.6.2 Copper IUCD
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Intrauterine Contraceptive Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Gynecological Clinics
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Intrauterine Contraceptive Market: Competitive Dashboard
   14.2 Global Intrauterine Contraceptive Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Teva Pharmaceutical Industries
      14.3.2 Medicines360
      14.3.3 Trimedic Supply Network
      14.3.4 Bayer Healthcare
      14.3.5 Actavis
      14.3.6 Medisafe Distribution
      14.3.7 Pace Pharmaceuticals
Segments Covered in the Report
The global Intrauterine Contraceptive market has been segmented based on

By Types
  • Hormonal IUCD
  • Copper IUCD
By Applications
  • Hospitals
  • Gynecological Clinics
  • Other
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Teva Pharmaceutical Industries
  • Medicines360
  • Trimedic Supply Network
  • Bayer Healthcare
  • Actavis
  • Medisafe Distribution
  • Pace Pharmaceuticals

Buy Report